Public Opinion on Legalizing Psychedelics
ResearchPublished Feb 24, 2026
An increasing number of U.S. states are implementing or considering changes to psychedelics policies. Using data from the 2025 RAND Psychedelics Survey, the authors examine public opinion about legalizing psilocybin mushrooms, LSD, and MDMA. For each substance, the authors asked whether use should be legal, for which reasons, and how substances should be supplied if made legal (e.g., at a medical facility under supervision, sold in dispensaries).
ResearchPublished Feb 24, 2026
An increasing number of U.S. states are implementing or considering changes to psychedelics policies. To help improve policy discussions and provide baseline information to ground these debates, the authors fielded the 2025 RAND Psychedelics Survey (RPS). The 2025 RPS is the first probability-based and nationally representative survey to measure U.S. public opinion about legalizing three psychedelic substances: psilocybin mushrooms, LSD, and MDMA. For each substance, the authors asked whether use should be legal, for which reasons adults should be allowed to use the substances, and how they should be supplied if made legal (e.g., at a medical facility under supervision, sold in dispensaries). For comparison purposes, the authors also included questions about whether using cannabis and cocaine should be legal.
This research was supported by DAFgiving360 and conducted by the RAND Drug Policy Research Center.
This publication is part of the RAND research report series. Research reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND research reports undergo rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.